SERUM LEVELS OF SOME CYTOKINES (GM-CSF, IL-10, IL-12 AND IL-17A) IN GENERALIZED ERYTHEMA MULTIFORME
Main Article Content
Abstract
We conducted this study sectional descriptive to investigate serum concentrations of some cytokines: Granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-10, IL-12, and IL-17A in generalized erythema multiforme. It was conducted at the National Hospital of Dermatology and Venereology, in Hanoi, Vietnam, from April 2017 to August 2019. Serum GM-CSF, IL-10, IL-12, and IL-17A concentrations were quantified by using the fluorescence covalent microbead immunosorbent assay. The mean age of the EM patients was 42.2. There were 22 patients (66.7%) with illness duration of less than 1 week. There were 60.6% of patients with a history of using medicine before onset. Only 15.2% of patients had mucosal lesions. In the EM group, serum concentrations of GM-CSF, IL-12, and IL-17A were 5.43±13.22 pg/ml, 0.92±2.19 pg/ml, and 0.28±0.29 pg/ml, respectively, significantly lower than those in HCs group, with p<0,01. Serum levels of GM-CSF, IL-12, and IL-17A in the HCs group were 31.99±31.64 pg/ml, 5.47±4.5 pg/ml, and 1.46±2.18 pg/ml, respectively. The serum concentration of IL-10 in the EM group was 9.86±15.29 pg/ml, not different from that in the EM group (11.84±11.09 pg/ml). There was no correlation between serum levels of cytokines with age in the EM group.
Article Details
Keywords
erythema multiforme, granulocyte-macrophage colony-stimulating factor, interleukin-10, interleukin-12, interleukin-17A
References

2. Patel PM, Jones VA, Murray TN, Amber KT. A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita. Am J Clin Dermatol. 2020;21(4):557-565. doi:10.1007/s40257-020-00513-3


3. Shah SN, Chauhan GR, Manjunatha BS, Dagrus K. Drug induced erythema multiforme: two case series with review of literature. J Clin Diagn Res JCDR. 2014;8(9):ZH01-04. doi:10. 7860/JCDR/2014/10173.4761


4. Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin North Am. 2013;57(4):583-596. doi:10.1016/j.cden.2013.07.001


5. Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J. 2003;9(1):1.

6. Ho A.W. and Kupper T.S. (2019). Soluble mediators of the cutaneous immune system. Fitzpatrick's Dermatology, 9th edition, McGraw Hill Education, p. 159-192.

7. Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm. 2013;2013:165974. doi:10.1155/2013/ 165974


8. Akkurt ZM, Uçmak D, Türkcü G, Yüksel H, Yildiz K, Arıca M. Expression of interleukin-17 in lesions of erythema multiforme may indicate a role for T helper 17 cells. Cent-Eur J Immunol. 2014;39(3):370-376. doi:10.5114/ceji.2014.45950


9. Quaglino P, Caproni M, Osella-Abate S, et al. Serum interleukin-13 levels are increased in patients with Stevens-Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme. Br J Dermatol. 2008; 158(1):184-186. doi:10.1111/j.1365-2133.2007. 08259.x


10. Hashizume H, Fujiyama T, Tokura Y. Reciprocal contribution of Th17 and regulatory T cells in severe drug allergy. J Dermatol Sci. 2016;81(2): 131-134. doi:10.1016/j.jdermsci. 2015.11.002

